STING1 and neoplasm: Interestingly, knocking out STING in MC38 tumor cells (Supplementary Fig. 21) but not C57BL/6 mice maintained the therapeutic effect of LID + US (Fig. 5n), indicating the STING pathway in the host rather than in tumor cells was mainly responsible for the therapeutic effect of LID + US.